Robert L. Balster, Ph.D.

← Back to faculty directory

Robert BalsterRobert L. Balster, PhD

Butler Professor of Pharmacology and Toxicology
Affiliate Professor of Psychology and Psychiatry
410 North 12th Street
R. Blackwell Smith Building Room 746A
Box 980310
Richmond, Virginia 23298-0316
Phone: (804) 828-8402
Publications: selected | PubMed

Education:  PhD University of Houston, 1970
Post-Doctoral Fellowship University of Chicago, 1970-72

Scholarly Interests:  drug abuse potential assessment and medication development, tobacco regulatory science, science policy, global health, training

Dr. Balster was the Founding Coordinator for the VCU site for the U.S. State Department Humphrey Fellowship Program in Substance Abuse Prevention, Treatment and Policy, and continues to work on that program.  He is also a co-founder and co-director of the International Programme in Addiction Studies, an online master’s degree program.  From 2006-2015 he also co-directed the Virginia Youth Tobacco Project, a statewide coalition of tobacco scientists supported by funds from the Master Settlement Agreement.  From 1997-2013 Dr. Balster was the Director of the VCU Institute for Drug and Alcohol Studies and from 2011-2012, he was selected as a Jefferson Science Fellow with the Global Health Bureau at the US Agency for International Development and served until 2015 as a Science Advisor for the Office of Health, Infectious Diseases and Nutrition at USAID.  He is a Past‑President of the CPDD and a former member of the WHO Expert Advisory Panel on Drug Dependence and the FDA Drug Abuse Advisory Committee.  From 1998 to 2010 he was the Editor-in-Chief of the international journal Drug and Alcohol Dependence.  In 2014 he was Chair of the WHO Guideline Development Group on the Management of Opioid Dependence.

Dr. Balster began his career in behavioral pharmacology research and the development of animal models for the abuse-related effects of drugs, including work on drug discrimination and drug self-administration.  He has worked with nearly every class of abused drugs but he published most extensively in the areas of NMDA antagonist pharmacology and the study of abused inhalants.  In recent year, Dr. Balster has turned his attention primarily to the areas of research administration, translational and implementation science, tobacco regulatory science, international health, and training program development.  In addition to publishing more than 280 papers in scientific journals, Dr. Balster has edited two books and authored over 50 book chapters.

Some Recent Publications:

Balster, R.L.  Inhalant abuse.  In:  Stolerman, I.P. and Price, L.H. (Eds.) Encyclopedia of Psychopharmacology, 2nd Edition.  Berlin Heidelberg: Springer-Verlag, pp. 805-808, 2015.

Balster, R.L. and Walsh, S.L.  Abuse liability assessment.  In:  Stolerman, I.P. and Price, L.H. (Eds.) Encyclopedia of Psychopharmacology, 2nd Edition.  Berlin Heidelberg: Springer-Verlag, pp. 2-7, 2015.

Balster, R.L., Levy, S. and Stammer, E.  Evidence acquisition and evaluation for the Evidence Summit on Population-Level Behavior Change to Enhance Child Survival and Development in Low- and Middle-Income Countries.  Journal of Health Communication, 19(Suppl. 1): 10-24, 2014.

Balster, R.L. The pharmacology of inhalants. In: Ries, R.K., Fiellin, D.A., Miller, S.C. and Saitz, R. (Eds.) The ASAM Principles of Addiction Medicine. 5th edition, Philadelphia: Wolters Kluwer, pp. 267-276, 2014.

Boothby, N., Balster, R.L., Goldman, P., Wessells, M.G,  Zeanah, C.H., Huebner, G. and Garbarino, J. Coordinated and evidence-based policy and practice for protecting children outside of family care.  Child Abuse & Neglect 10:743-51, 2012.

Balster, R.L., Cruz, S.L., Howard, M.O., Dell, C.A. and Cottler, L.B.  Classification of abused inhalants.  Addiction 104:878-882, 2009.